SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending following its recent earnings report, which, despite beating analyst expectations on key metrics, saw the stock experience a notable drop. Bulls view this as an oversold opportunity to buy, highlighting robust subscriber growth and expanding ad revenue, while bears point to cautious forward guidance and the pause in share buybacks as concerns, especially with the ongoing Warner Bros. acquisition discussions.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is trending due to surging natural gas futures prices, driven by forecasts of an extensive arctic cold snap and polar vortex across the US. This weather-driven demand is igniting a significant short squeeze, with the community actively discussing potential further upside and extreme volatility for leveraged natural gas products.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is experiencing a powerful rally to record highs, driven by heightened geopolitical tensions, particularly concerns surrounding President Trump's tariff threats against European allies over Greenland. The community is actively discussing gold's role as a vital safe-haven, with many viewing it as a critical hedge against market instability and potential dollar weakness in a "risk-off" environment. This reflects a broad shift towards tangible assets amidst global uncertainty.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is driving significant conversation due to recent analyst upgrades and reports of a substantial U.S. SHIELD defense contract, further highlighting its strategic importance in domestic chip manufacturing. The community is actively discussing expectations for an upcoming earnings report, with sentiment boosted by reports of Intel's 2026 server CPU capacity being largely sold out amidst growing AI demand.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is trending amidst extreme volatility in natural gas prices, driven by rapidly shifting winter weather forecasts and a continuous tug-of-war between strong production and potential heating demand. The community is intensely focused on trading this inverse ETF, attempting to capitalize on sharp swings while navigating its 'widowmaker' reputation and inherent decay.

America's Oil Reserve for the Digital Age

U.S Oil

US Oil Token (USOR) is currently trending due to highly volatile price action, sparking intense debate within the crypto community regarding its legitimacy. Many are warning of a potential "rug pull" or "pump and dump," while others are aggressively buying, anticipating significant gains tied to a speculated event by February 1st. Adding to the speculative fervor, prospective investors are actively seeking clarity on where to reliably purchase the Solana-based token amidst concerns about fake versions.

United States Commodity Funds LLC - United States Natural Gas Fund

United States Natural Gas Fund, LP

The United States Natural Gas Fund ($UNG) is experiencing significant upward momentum driven by widespread forecasts for brutal arctic cold and winter storms across key demand regions, sparking intense bullish sentiment. This sharp rebound is fueling active community debate, with many traders anticipating a short squeeze while others remain wary of natural gas's historical volatility and high production levels. Beyond immediate weather, the community is also discussing increasing long-term demand from LNG exports and emerging needs from AI data centers.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending due to reports of Zydus Lifesciences considering a significant equity stake or acquisition, following a critical patent extension for its key products until 2041. The community is actively discussing a potential bidding war, believing the company's strong revenue trajectory and extended intellectual property runway make it considerably undervalued. Many see the patent extension as a "game changer," significantly enhancing the company's long-term appeal to major pharmaceutical players.

SSgA Active Trust - State Street Consumer Staples Select Sector SPDR ETF

Consumer Staples Select Sector SPDR Fund

The Consumer Staples Select Sector SPDR Fund (XLP) is trending as investors increasingly seek defensive assets, positioning it as a safe haven amidst broader market uncertainties. The community is actively discussing a significant sector rotation, with XLP experiencing a notable rally and challenging key technical resistance levels after a period of underperformance. Many view this shift as smart money moving into "risk-off" assets, highlighting the sector's potential for stability and continued upside.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

Invesco QQQ Trust is a major talking point as market participants react to escalating geopolitical rhetoric, particularly concerning Greenland and potential tariffs, which are generating global trade stability concerns. Community discussion reflects a stark divide, with some anticipating a significant market pullback, while a strong "buy the dip" mentality persists among others, especially with upcoming tech developments. This broader environment of policy uncertainty and global economic shifts keeps the tech-heavy index in focus.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Meitav Investment House Ltd. Has $5.24 Million Stock Holdings in MediWound Ltd. $MDWD

Meitav Investment House Ltd. grew its position in shares of MediWound Ltd. (NASDAQ:MDWD - Free Report) by 825.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with...

MediWound Ltd. (NASDAQ:MDWD) Given Consensus Recommendation of "Moderate Buy" by Analysts

MediWound Ltd. (NASDAQ:MDWD - Get Free Report) has earned an average rating of "Moderate Buy" from the six brokerages that are currently covering the company, Marketbeat Ratings reports. One analyst...

MediWound (NASDAQ:MDWD) Share Price Crosses Below Two Hundred Day Moving Average - Time to Sell?

MediWound (NASDAQ:MDWD) Share Price Passes Below 200 Day Moving Average - Here's What Happened...

MediWound (NASDAQ:MDWD) Shares Pass Above 50 Day Moving Average - What's Next?

MediWound (NASDAQ:MDWD) Stock Price Crosses Above 50 Day Moving Average - What's Next...

MediWound Ltd. (NASDAQ:MDWD) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of MediWound Ltd. (NASDAQ:MDWD - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the six ratings firms that are presently covering the stock, MarketBeat reports...

MediWound (NASDAQ:MDWD) Stock Passes Above 50-Day Moving Average - What's Next?

MediWound (NASDAQ:MDWD) Stock Crosses Above 50 Day Moving Average - What's Next...

MediWound Ltd. (NASDAQ:MDWD) Receives Average Rating of "Moderate Buy" from Analysts

MediWound Ltd. (NASDAQ:MDWD - Get Free Report) has received an average rating of "Moderate Buy" from the six research firms that are covering the stock, MarketBeat.com reports. One equities research...

MediWound (NASDAQ:MDWD) Announces Earnings Results

MediWound (NASDAQ:MDWD - Get Free Report) released its quarterly earnings data on Thursday. The biopharmaceutical company reported ($0.24) EPS for the quarter, beating analysts' consensus estimates...

MediWound (MDWD) Reports Q3 Loss, Misses Revenue Estimates

MediWound (MDWD) delivered earnings and revenue surprises of +70.37% and -15.52%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

IGC Pharma, Inc. (IGC) Reports Q2 Loss, Misses Revenue Estimates

IGC Pharma, Inc. (IGC) delivered earnings and revenue surprises of 0.00% and -56.59%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.

MediWound Ltd

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.60	--	--	N/A
Q3 '25	-$0.81	-$0.24	70.43%	BEAT
Q2 '25	-$0.57	-$1.23	-114.85%	MISSED
Q1 '25	-$0.66	-$0.07	89.42%	BEAT
Q4 '24	-$0.58	-$0.36	37.50%	BEAT

MDWD
MediWound Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest MDWD News

MDWDMediWound Ltd